Systemic delivery of glycosylated-PEG-masked oncolytic virus enhances targeting of antitumor immuno-virotherapy and modulates T and NK cell infiltration

Rationale: Immuno-virotherapy has emerged as a promising approach for cancer treatment, as it directly and cytotoxically eliminates tumors with systemic immune stimulation. However, the clinical efficacy of this approach remains limited by inappropriate delivery routes, robust antiviral responses, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Yuzhi, Wang, Bing, Chen, Qingjing, Fu, Xingyue, Jiang, Chenwei, Lin, Zhiwen, Zhuang, Qiuyu, Zeng, Yongyi, Liu, Xiaolong, Zhang, Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614686/
https://www.ncbi.nlm.nih.gov/pubmed/37908722
http://dx.doi.org/10.7150/thno.87498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614686/
https://www.ncbi.nlm.nih.gov/pubmed/37908722
http://dx.doi.org/10.7150/thno.87498

Ejemplares similares